NASDAQ:DERM | Free Cash Flow | Journey Medical Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$2.91M
2025-12-31-$6.28M
2025-03-31-$2.83M
2024-12-31$2.23M
2024-03-31-$5.02M
2023-12-31-$16.52M
2023-03-31-$956,000.00
2022-12-31-$3.84M
2022-03-31$884,000.00
2021-12-31-$3.21M
2021-03-31$1.36M
2020-12-31$5.05M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$12.44M
2024-12-31-$9.13M
2023-12-31$5.24M
2022-12-31-$13.53M
2021-12-31-$2.18M
2020-12-31$5.13M